For investors only

All about the drug candidate arfolitixorin
and related information

ASCO-GI 2020, poster

Isofol will attend the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO-GI), that is being held from January 23 – 25, 2020, in San Francisco. The presentation and poster presents details in the ongoing global Phase 3 AGENT clinical study (ISO-CC-007).

Information about the presentation

Title: AGENT: An open-label Phase III study of arfolitixorin vs leucovorin in modified FOLFOX-6 for first-line treatment of metastatic colorectal cancer

Presentation Number: TPS268

Presentation Time: 6:30 a.m. – 7:55 a.m.

Presentation Date: Saturday, January 25, 2020

Speaker: Heinz-Josef Lenz

Session Name: Trials in Progress Poster Session C: Anal and Colorectal Cancer

The poster will be available below at the same time:

Poster, ASCO-GI 2020 (2,4 Mb)

Link to the abstract >>

Last updated 05-22-2024